Home › Oropharyngeal Cancer › District of Columbia
Oropharyngeal Cancer clinical trials in District of Columbia
3 studies for Oropharyngeal Cancer are looking for participants at sites in District of Columbia.
Cities in District of Columbia
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
- George Washington University Medical Center, Washington D.C.
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT06532279Treatment De-Escalation for Favorable Prognosis Human Papilloma Virus (HPV) or p16-Positive Oropharyngeal Cancer Receiving Definitive Radiotherapy
- Medstar Georgetown University Hospital, Washington D.C.
Recruiting
Ages 18 and older · All sexes · Updated Apr 17, 2026 · NCT06902623De-escalation of Adjuvant Radiation for Low-Risk HPV Oropharyngeal Cancers
- Medstar Georgetown University Hospital, Washington D.C.
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Mar 23, 2026 · NCT06554158From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.